secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2022-03-24T23:59:59+00:00
Accession:  0001437749-22-007109
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo extends CFO engagement through Jan 2023; grants 300k-share option at $0.24
--------------------------------------------------------------------------------

- CFO Charles K. Dargan II engagement extended one year to January 31, 2023.
- Sole compensation: option to purchase 300,000 shares (25,000/month) at $0.24 per share.
- Option vests monthly beginning March 2022; no cash compensation for the term.
- Option granted under 2018 Equity Incentive Plan, expires ten years from grant date.
- Either party can terminate the agreement with 30 days' written notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774922007109/0001437749-22-007109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774922007109/blgo20220323_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-007109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer